Dr. Umesh Kumar Sabharwal, MD

Dr. Sabharwal practices at Jiva Health, Inc in Concord, California.

Dr. Sabharwal's NPI, 1831192160, was assigned on May 31, 2005. Dr. Sabharwal graduated from All India Institute of Medical Sciences in 1974. Dr. Sabharwal holds California license A34184.

Dr. Sabharwal's primary practice is Jiva Health, Inc, at 2182 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 685-4224.

Dr. Sabharwal's primary practice is Jiva Health, Inc in Concord, California. Dr. Sabharwal is also affiliated with Dignity Health - Sequoia Hospital. The medical group on file is Jiva Health. Dmand AI also links Dr. Sabharwal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabharwal practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sabharwal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sabharwal is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Sabharwal is licensed in California.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis and hives among the conditions Dr. Sabharwal treats.

CMS data shows 115 Medicare services from Dr. Sabharwal across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $9,160 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Sabharwal in 2024. The largest group is 75 to 84, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sabharwal's median patient age at 50, with 48% women.

In 2024, Dr. Sabharwal wrote 244 Medicare Part D claims for 38 patients. 86% of them were for generic drugs. CMS names the drug for 94 of them, across 6 drugs with 11 or more claims each, at $80,564 in total drug cost. In 2023, CMS named 333 claims across 15 drugs.

Dr. Sabharwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sabharwal as offering telehealth.

Dmand AI links 21 papers to Dr. Sabharwal. The most frequent topics are Immunoglobulin G, Complement Activation and Complement C4. Dr. Sabharwal has published most often in Indian J Med Res. Dr. Sabharwal's most frequent co-authors are Elias Anaissie, MD, Dimitrios P. Kontoyiannis, MD and Kent A. Swanson, MD.

CMS Open Payments shows 1,061 general payments to Dr. Sabharwal from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Amgen Inc. paid the most, $9,297.

Dmand AI lists 1 award for Dr. Sabharwal, most recently CMS Stage 1 EHR in 2014.

Dr. Sabharwal graduated from All India Institute of Medical Sciences in 1974.

Dr. Sabharwal is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.